gentamicin at the University of Alberta Hospital in Edmonton, Canada. Of 45 gentamicin-resistant strains from that hospital, none possessed R-factors or gentamicin-inactivating enzymes. Eight of 13 strains obtained from three American sources, which contained gentamicin-acetylating (12 strains) or -adenylating (1 strain) activity, conjugally transferred both gentamicin resistance and antibiotic-inactivating activity. P. aeruginosa recipients were much more effective for detection of transferable gentamicin resistance than Escherichia coli recipients, although not all P. aeruginosa were equally as effective as recipients. One strain, POW 151, transferred resistance to both carbenicillin and gentamicin as well as to several other antibiotics. R-factors detected belonged to P-2 and P-3 (Com 6, C) incompatibility groups. Expression of gentamicin resistance due to acetylation of gentamicin was subject to marked phenotypic lag, especially in recipient strain P. aeruginosa 280. This was shown to result in the failure to detect gentamicin resistance transfer if the concentration of gentamicin in selection media was too high ( > 2.5 ,g/ml for strain 280). Some but not all recipients were changed in pyocine type upon acquisition of R-factors.
Antibiotic therapy of infections due to Pseudomonas aeruginosa has been limited mainly to carbenicillin, colistin, or gentamicin. Recently, the aminoglycosides tobramycin and BBK-8 have shown potential therapeutic promise by in vitro antibiotic susceptibility testing (4, 17) . The frequency of resistance to gentamicin among strains of P. aeruginosa has been reported by several groups (10, 13, 14) . Resistance has been a particular problem in the treatment of burns where large quantities of topical gentamicin cream have been used frequently. Resistance to gentamicin in general hospitals has been apparently less of a problem, although the rate of gentamicin resistance seems to be increasing (10) . The mechanism of gentamicin resistance has been partly defined. Inactivation of gentamicin by acetylation (7, 19) and by adenylation in strains of P. aeruginosa has been described. R-factor-mediated transfer of gentamicin resistance in P. aeruginosa has been demonstrated by our own group (5) and by G. A. Jacoby (Abstr. Annu. Meet. Amer. Soc. Microbiol., p. 67, 1973 ). Chabbert and Witchitz demonstrated R-factor-mediated gentamicin resistance (in Europe) in members of the Enterobacteriaceae and strains of P. aeruginosa (9) . In this instance, the gentamicin was inactivated by adenylation. Kabins et al. (S. A. Kabins, C. R. Nathan, and Sidney Cohen, Prog. Abstr. Intersci. Conf. Antimicrob. Ag. Chemother., 13th, Washington, D.C., Abstr. 187, 1973) recently reported the presence of urinary isolates of P. aeruginosa capable of gentamicin adenylation.
We recently surveyed strains of P. aeruginosa at the University of Alberta Hospital (UAH) to detect the overall frequency of gentamicin resistance there, as well as the frequency of R-factor-specified gentamicin resistance. Also examined for R-factors were several strains of P. aeruginosa resistant to gentamicin obtained from American sources, primarily from burn cases. We report here the results of these studies and some practical problems important in detecting transferable gentamicin resistance. MIC of antibiotics. Minimal inhibitory concentrations (MIC) were determined in Trypticase soy broth as described (6) .
Mating methods. Mating methods and selection of R+ recipients (transconjugants) were carried out as described previously (6) by using 2-h matings with 1: 10 donor-to-recipient bacterial ratios.
To determine the expression of gentamicin and streptomycin resistance in recipients at different times after R-factor transfer to the recipient, the following procedures for mating were carried out. Donor strain 130 (R130) (5 x 107 cells per ml) was mixed with recipient strain 280 met-Rifr (5 x 108 cells per ml) and mated at 37 C for 2 h (6). After termination of the mating period, rifampin (100 JLg/ml) and streptomycin (16.5 Ag/ml) were added to kill donor (rifampin-sensitive) and recipient (streptomycin-sensitive) cells to prevent further conjugation. Control studies showed that the number of donor and recipient cells after 3 h of exposure to these drugs was less than 500 colony-forming units per ml. The end of the 2-h mating period was assigned zero time. At this time, and at intervals of 3, 6, 9, and 18 h thereafter, samples were removed, appropriately diluted, and plated in triplicate on a medium of trypticase soy with 1.5% agar containing 100 Mg of rifampin per ml and either gentamicin (1 gg/ml) or streptomycin (16.5 gg/ml). Corrected transfer frequencies were obtained by dividing the observed transfer frequency by the number of replications of control R+ recipients grown under similar conditions.
Assay for antibiotic-inactivating enzymes. Bacterial strains were grown in Trypticase soy broth with or without gentamicin (0.1 to 1 uLg/ml) to an absorbance of 0.5 at 600 nm (Beckman DBG spectrophotometer), and harvested by centrifugation at 4 C at 10,000 x g for 10 min. The pellet was washed once with a buffer containing 10 mM Tris-hydrochloride, 50 mM NH4 Cl, 10 mM MgCl2, and 2 mM dithiothreitol (pH 7.8), and suspended in the same buffer. Cells were disrupted by sonic oscillation (Biosonik III, 0.95-cm probe size) for 1 min in an ice bath, and centrifuged at 4 C at 12,000 x g for 60 min. The resulting supernatant was then recentrifuged at 4 C at 30,000 x g for 60 min. The final supernatant was assayed for gentamicin-acetylating or -adenylating activity or streptomycin phosphotransferase, by the methods of Benveniste and Davies (2) . Carbenicillinase assays were determined by the Perret method (20) , and protein was determined by the Lowry method (18) . To determine the level of antibiotic-inactivating enzymes in R+ recipients in the 18-h period following the mating, 75 ml of each of the donor (5 x 107 cells per ml) and the recipient (5 x 108 cells per ml) were mixed in Povitsky bottles positioned with the flat side down. At the end of the 2-h mating period, rifampin and streptomycin were added as described in the mating procedures. At 0, 3, 6, 9, and 18 h after the mating period, 300-ml samples of the mating mixture were washed and used ANTIMICROB. AG. CHEMOTHER.
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Pyocine typing. For pyocine typing, the method of Govan and Gillies was used (15) . Incompatibility (or compatibility) studies. The frequency of R-factor transfer to R-and R+ recipients, and the stability of two R-factors in a single recipient strain was determined as described previously (5) . Physical studies to detect extrachromosomal DNA. Analytical CsCl density gradient centrifugation of phenol-extracted deoxyribonucleic acid (DNA) and ethidium bromide-CsCl density gradient centrifugation of Sarkosyl-lysozyme-lysed cells were performed as previously described (5) . 32P-labeling of DNA was carried out using a low-phosphate medium and 10 gCi of 32P per ml as described (5) . RESULTS Frequency of gentamicin resistance. The results of routine antimicrobial susceptibility testing for a 4-month period in late 1973, performed at the UAH general diagnostic laboratory using a standard disk diffusion procedure (1) , is shown in Table 2 . Strains considered resistant or moderately resistant by testing criteria comprised 42% of all strains. These strains had MIC values performed in Trypticase soy broth (6) ranging from 6.25 to 100 jig/ml.
Strains considered resistant were 11% of the total, and the range of MIC values was 12.5 to 100 Ag/ml. The number of resistant strains has about tripled from 3.5% in a similar period 1 year earlier. Most of these strains have MIC values of about 25 to 50 ,g/ml. Similarly, strains considered moderately resistant by Kirby-Bauer criteria in the same time period have increased from less than 10 to 31%. Whereas some of these strains represent repeated testing of the same strain, no significant difference in this respect occurred in the two testing periods (1972 and 1973) . Thus, it is apparent that resistance to gentamicin, particularly lower level gentamicin resistance (<6.5 to 12.5 Ag/ml), is increasing fairly rapidly at the UAH. Gentamicin is a commonly used antibiotic in the hospital and its use has increased steadily over the past several years. For the 4-month period reported (July to October 1973), use has increased by 127% (184, 320 mg versus 81, 120 mg). Strains resistant to gentamicin were followed up by pyocine typing (15) and, in many instances, by examination of the clinical circumstances involving the strains. Pyocine typing patterns showed a wide distribution of individual types, but none were predominant. These results tend to argue against the spread of a single or few types of resistant P. aeruginosa.
The clinical circumstances involved demonstrated that strains came from many different hospital wards and cases. The most common cases involved were burns, skin infections other than bums, wound and urinary tract infections, and bronchopneumonia.
Survey of UAH strains for R-factor-mediated gentamicin resistance. Forty-five strains of P. aeruginosa, having MICs between 6.25 and 100 jig/ml for gentamicin, were examined for R-factors by conjugation experiments. We routinely used Escherichia coli 1306 and two P. aeruginosa strains (280 and one of strains 1310, 3503, or 7412) as recipients. No R-factors were detected in these strains (Table 3 ). All 45 strains also failed to contain gentamicinacetylating or -adenylating activity. Representative members of these strains are currently under more intensive investigation to determine their mechanism of resistance to gentamicin. However, based upon the methods we used, they do not contain R-factors.
Examination for transferable antibiotic resistance in strains of P. aeruginosa which inactivate gentamicin. We obtained 13 strains of P. aeruginosa from three outside sources (Table 1) . Three strains were obtained because of known gentamicin-acetylating activity (strains 130, 209, PST-1) (7), one strain for gentamicin-adenylating activity (POW 151) (Kabins et al., Prog. Abstr. Intersci. Conf. Antimicrob. Ag. Chemother., 13th, Washington, D.C., Abstr. 187, 1973); nine strains obtained were resistant to gentamicin but not to tobramycin, and originated from bum cases ( Table 1 ). All of these strains had MIC values for gentamicin of 100 ,g/ml or greater. The nature of the gentamicin inactivation in the last set of strains was unknown, but was shown to be due to gentamicin acetyltransferase I, in that kanamycin A was not acetylated and tobramycin was a poor substrate in acetylating assays (3) .
The results of conjugation experiments carried out to detect R-factors are shown in (Table 5) . P-2 R-factors are the most common group R-factors we have detected in strains of P. aeruginosa. R-factor POW 151 (p LB 151) belongs to the P-3 (Com 6, C) incompatibility group of plasmids (8, 11, our unpublished data; Table 5 ). R-factor 151 is unstable in P. aeruginosa strain 280, although it readily transfers to that strain. In strain 280, the R-factor is spontaneously cured in 90% of clones by the fifth transfer in drug-free medium. It is, how- (Table 7) . This is exemplified by noting that the resistance transfer frequency obtained for streptomycin is 3,000 to 5,000 times that obtained for gentamicin (selection at 1 ,ug of gentamicin per ml) immediately following a 2-h mating period (Table 7) . However, further mating was prevented, as in the, experiment shown in Table 7 , and the apparent mating frequency at various times was followed after adjustment for replication of the R+ recipient (transconjugant) cells. The apparent frequency of gentamicin-resistance transfer, in the absence of further mating, gradually increases with time to equal that of streptomycin-resistance transfer at 18 h after the end of the mating. Additionally, clones selected on streptomycin at any time in the 18-h period following mating were shown by replica plating to gentamicin plates (2.5 jig/ml) to be gentamicin resistant. The specific activity of gentamicin acetyltransferase also increased with time following the mating period (Fig. 1) .
Phenotypic lag of expression of gentamicin resistance is most marked in strain 280, but also occurs in other recipient strains of P. aeruginosa (strains 1310, 3503). Strain 280 has the broadest recipient capabilities of any P. aeruginosa we have examined so far and, thus, is a very useful recipient.
The result of the phenotypic lag is shown by comparing apparent transfer frequencies of gentamicin resistance from strain 130 (R130) to strain 280 at selection concentrations of 10, 5, 2.5, and 1 ,ug/ml. There was a profound decrease in frequency with increasing gentamicin concentration, i.e., concentrations of 1, 2.5, 5, and 10 jig/ml had transfer frequencies of 3 x 10-3, 2 x 10-6, 0, and 0, respectively (the mating period of 130 (R130) x 280 met-Rif was 2 h; rifampin concentration was 100 ,ug/ml in all plates). Higher gentamicin concentrations in selection medium could easily prevent detection of transferred gentamicin resistance. Significant phenotypic lag was not detected for gentamicin-resistance transfer with the R-factors specifying gentamicin-adenylating activity (R151, R55).
Pyocine typing of P. aeruginosa R+ recipients (transconjugants). We have observed that the acceptance of an R-factor by a recipient strain may change the pyocine type of that strain. This observation was also made by Jacoby (Abstr. Annu. Meet. Amer. Soc. Microbiol., p. 67, 1973). Thus, for example, the Rstrain 211 in Table 8 is pyocine type lh, whereas the R+ strain 211 (R130) is nontypable. The general effect observed is a decrease in the number of indicator strains inhibited by the R+ strain being examined for pyocine production. Not all R+ strains undergo change in pyocine type, for example strain 280 does not, whereas strains 3503, 211, and 7412 do. The differential effect on pyocine production by P-2 R-factors in various strains is dependent on the strain rather than the R-factor. For example, R130 is associated with no change in pyocine type in strain 280, but does cause a change in pyocine type in strain 3503. One significance of a change in pyocine type is that epidemiological study of a strain may be prevented by the acquisition of an R-factor. The reason for the R-factor effect on pyocine production is presently unknown. No change in pyocine type due to the P-3 (C, Com 6) R-factor 151 was detected. DISCUSSION The assessment of susceptibility to gentamicin is somewhat confused by the influence of testing medium (specifically divalent cations) on MIC values for P. aeruginosa. We used media (Mueller-Hinton agar; Trypticase soy broth) (BBL) that gave relatively low MICs of gentamicin, when compared to most other testing media (13) , in an effort to avoid an overestimation of the frequency of gentamicin resistance. In addition, the increase in resistance described for the periods in 1972 and 1973 occurred with exactly the same media and testing procedures. These precautions make it unlikely that the relatively high frequency of resistance reported is an artifact of our testing system.
The present study demonstrates several practical points about gentamicin resistance in P. aeruginosa. Gentamicin resistance is increasing, at least in the general hospital environment of the UAH. This increase has been associated with an increasing use of gentamicin in the hospital, much of which has been used to treat infections due to bacteria other than P. aeruginosa. Much of the increase in resistance has been of a low level type ( <6.5 to 12.5 Lg/ml) and has not involved the spread of any particular strain(s) in the hospital. Neither transferable resistance nor gentamicin-inactivating activity was detected in these types of strains, which are currently under further study with respect to their mechanism of resistance.
R-factors transferring gentamicin resistance in strains of P. aeruginosa did occur in selected strains and generally specified higher level gentamicin resistance (100 ug/ml or greater). Of the eight R-factors we detected, all specified gentamicin-inactivating enzymes. The demonstration of all such R-factors was, in our experience, more readily done using P. aeruginosa than E. (12) showed phosphorylation of streptomycin, whether these enzyme activities were chromosomally or R-factor specified was unknown. This study demonstrates that gentamicin acetylation and adenylation may be frequently specified by R-factors in P. aeruginosa. We have also shown this to be true for streptomycin phosphorylation (22) and in this paper for streptomycin adenylation. Jacoby,also confirmed transferability of gentamicin acetyltransferase (Abstr. Annu. Meet. Amer. Soc. Microbiol., p. 67, 1973) . Thus from our studies and those of Sykes and Richmond (21), Fullbrook et al. (14) , and Chabbert and Witchitz (9), it is clear that aminoglycoside-inactivating enzymes and betalactamases are, at least in many cases, R-factor specified in P. aeruginosa. A major reason contributing to the difficulty in determining genetic location of this information has been the difficulty encountered in transferring antibiotic resistance due to the sole use of E. coli as a recipient for Pseudomonas R-factors.
The fact that many of the above antibioticinactivating enzyme activities are R-factor mediated does not exclude other antibioticinactivating enzymes from being chromosomally specified. Strain PST-1 may be such an example. However, caution should be used in excluding potential resistance transfer for the several reasons given above.
We did not detect any R-factors of the P incompatability group, and, to our knowledge, no such R-factors carrying gentamicin resistance have been described.
It is difficult to give any accurate estimation of the overall frequency and importance of R-factors of gentamicin resistance in P. aeruginosa strains. The group of strains selected, as shown here, gives quite different answers as to R-factor frequency. It is becoming clear to us that many strains of P. aeruginosa are resistant to gentamicin for reasons other than gentamicin inactivation and R-factorspecified resistance. The 45 UAH strains are apparently free of such mechanisms (manu-ANTIMICROB. AG. CHEMOTHER.
on November 2, 2017 by guest http://aac.asm.org/ Downloaded from script in preparation). Thus, while R-factors are of obvious importance, other resistance mechanisms apparently do exist and could be of major significance.
